MYCELX Technologies Corporation
MYX.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £4,903 | £10,907 | £10,026 | £8,478 |
| % Growth | -55% | 8.8% | 18.3% | – |
| Cost of Goods Sold | £3,559 | £7,017 | £5,584 | £5,203 |
| Gross Profit | £1,344 | £3,890 | £4,442 | £3,275 |
| % Margin | 27.4% | 35.7% | 44.3% | 38.6% |
| R&D Expenses | £219 | £248 | £218 | £223 |
| G&A Expenses | £5,435 | £6,734 | £0 | £6,939 |
| SG&A Expenses | £5,466 | £6,743 | £7,589 | £6,939 |
| Sales & Mktg Exp. | £31 | £9 | £7,589 | £0 |
| Other Operating Expenses | £212 | £231 | £210 | £205 |
| Operating Expenses | £5,897 | £7,222 | £8,017 | £7,367 |
| Operating Income | -£4,553 | -£3,332 | -£3,575 | -£1,508 |
| % Margin | -92.9% | -30.5% | -35.7% | -17.8% |
| Other Income/Exp. Net | £1,915 | -£9 | £2 | £379 |
| Pre-Tax Income | -£2,638 | -£3,341 | -£3,573 | -£1,129 |
| Tax Expense | £85 | £365 | £418 | £296 |
| Net Income | -£2,723 | -£3,706 | -£3,991 | -£1,425 |
| % Margin | -55.5% | -34% | -39.8% | -16.8% |
| EPS | -0.12 | -0.16 | -0.18 | -0.073 |
| % Growth | 25% | 11.1% | -145.6% | – |
| EPS Diluted | -0.12 | -0.16 | -0.18 | -0.073 |
| Weighted Avg Shares Out | 23,429 | 22,983 | 22,215 | 19,444 |
| Weighted Avg Shares Out Dil | 23,429 | 22,983 | 22,215 | 19,444 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £13 | £9 | £0 | £24 |
| Depreciation & Amortization | £398 | £868 | £1,091 | £1,124 |
| EBITDA | -£2,227 | -£2,464 | -£2,482 | £19 |
| % Margin | -45.4% | -22.6% | -24.8% | 0.2% |